You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

Ranitidine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Recent Clinical Trials for ranitidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kasr El Aini HospitalN/A
Menoufia UniversityPhase 2/Phase 3
Cairo UniversityN/A

See all ranitidine clinical trials

Generic filers with tentative approvals for RANITIDINE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up15MG/MLSolution; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for ranitidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novitium Pharma RANITIDINE HYDROCHLORIDE ranitidine hydrochloride CAPSULE;ORAL 210681-001 Nov 23, 2018 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo R And D RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 091429-001 May 11, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo R And D RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 091429-002 May 11, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Inc RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 076705-002 Jul 27, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva RANITIDINE HYDROCHLORIDE ranitidine hydrochloride CAPSULE;ORAL 075557-002 Oct 31, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.